Skip to main content

Varicose Veins News

FDA Approves Varithena (Polidocanol Injectable Foam) for the Treatment of Patients with Varicose Veins

LONDON, November 26, 2013 /PRNewswire/ – BTG plc (LSE: BTG), the specialist healthcare company, today announces that the US Food and Drug Administration (FDA) has approved Varithena(TM) (polidocanol...

FDA Approves Asclera to Treat Small Varicose Veins

ROCKVILLE, Md., March 30, 2010--The U.S. Food and Drug Administration today approved Asclera (polidocanol) injection for the treatment of small types of abnormally swollen or twisted veins called...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Cardiovascular Conditions and Disorders